Parkside Financial Bank & Trust’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Parkside Financial Bank & Trust's TXG Position: Q1 2026 in Review
Parkside Financial Bank & Trust held its 10x Genomics (TXG) position steady in Q1 2026 at 748 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.
Parkside Financial Bank & Trust first reported a position in TXG in Q4 2020 and has held it in 22 quarters since. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- Parkside Financial Bank & Trust held 748 shares of 10x Genomics worth $15.9K as of Q1 2026.
- Parkside Financial Bank & Trust left its 10x Genomics share count unchanged in Q1 2026.
- 10x Genomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1400 holding.
- Parkside Financial Bank & Trust first reported a position in 10x Genomics in Q4 2020 and has held it in 22 quarters since.
- 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.